Xenon Pharmaceuticals (XENE) Return on Capital Employed (QoQ) (2015 - 2026)

Xenon Pharmaceuticals (XENE) Return on Capital Employed (QoQ) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Xenon Pharmaceuticals 5.71 Bn 5.71 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2,193.00
Dec 31, 2025 -793.00
Sep 30, 2025 -946.00
Jun 30, 2025 -741.00
Mar 31, 2025 -392.00
Dec 31, 2024 -497.00
Sep 30, 2024 -348.00
Jun 30, 2024 -293.00
Mar 31, 2024 271.00
Dec 31, 2023 411.00
Sep 30, 2023 -357.00
Jun 30, 2023 -510.00
Mar 31, 2023 -511.00
Dec 31, 2022 -314.00
Sep 30, 2022 -109.00
Jun 30, 2022 124.00
Mar 31, 2022 514.00
Dec 31, 2021 657.00
Sep 30, 2021 -328.00
Jun 30, 2021 -564.00